Scrutiny of the FDA’s Accelerated Approval Processes Should Be a Wakeup Call; It’s Time for Employers to Advocate for Precision Medicine

  • accurately diagnose and stage diseases;
  • determine what drugs might be beneficial or what drugs could cause a severe adverse reaction;
  • determine if a patient’s genetic profile makes them susceptible to certain diseases;
  • and critically, determine if a patient is/isn’t going to respond to a particular drug or therapeutic intervention.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Dr. Blake Long

Dr. Blake Long

CMO of Alva10; physician; investor. Dedicated to developing the necessary entrepreneurial ecosystem to support & advance precision medicine.